AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2012
Dec 21, 2012
34301_dirs_2012-12-21_e4163614-4f9b-42e5-a9e6-fdae9df54478.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2012-12-19
Reporting Person: RICKEY DAVID (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-19 | Common Stock | P | 20000 | $2.85 | Acquired | 108559 | Indirect |
| 2012-12-19 | Common Stock | P | 12000 | $2.85 | Acquired | 158101 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 34909 | Indirect |
| Restricted Stock Award (Common Stock) | 10000 | Direct |
Footnotes
F1: Mr. Rickey purchased the shares in connection with a public offering of company shares which closed on December 19, 2012.
F2: These securities are owned by the Dave Rickey and Daughters Foundation.
F3: These securities are owned by Dave Rickey, TTEE FBO the David Rickey Trust
F4: These securities are owned by David M Rickey, Trustee FBO The Rickey Annunity Trust.
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26